118 related articles for article (PubMed ID: 8025208)
1. Complement activation in patients with primary Sjögren's syndrome: an indicator of systemic disease.
Lindgren S; Hansen B; Sjöholm AG; Manthorpe R
Autoimmunity; 1993; 16(4):297-300. PubMed ID: 8025208
[TBL] [Abstract][Full Text] [Related]
2. Serum complement activation in central nervous system disease in Sjögren's syndrome.
Alexander EL; Provost TT; Sanders ME; Frank MM; Joiner KA
Am J Med; 1988 Oct; 85(4):513-8. PubMed ID: 3177398
[TBL] [Abstract][Full Text] [Related]
3. Complement inhibitor C4b-binding protein in primary Sjögren's syndrome and its association with other disease markers.
Zadura AF; Theander E; Blom AM; Trouw LA
Scand J Immunol; 2009 Apr; 69(4):374-80. PubMed ID: 19284503
[TBL] [Abstract][Full Text] [Related]
4. Hyperviscosity in primary Sjögren's syndrome: clinical implications.
Hernández-Molina G; Bermúdez-Bermejo P
Int J Rheum Dis; 2017 Jan; 20(1):84-89. PubMed ID: 26807556
[TBL] [Abstract][Full Text] [Related]
5. Complement C3b receptors on erythrocytes, circulating immune complexes, and complement C3 split products in patients with primary Sjögren's syndrome.
Thomsen BS; Oxholm P; Manthorpe R; Nielsen H
Arthritis Rheum; 1986 Jul; 29(7):857-62. PubMed ID: 2943291
[TBL] [Abstract][Full Text] [Related]
6. Primary Sjogren's syndrome as a multi-organ disease: impact of the serological profile on the clinical presentation of the disease in a large cohort of Italian patients.
Baldini C; Pepe P; Quartuccio L; Priori R; Bartoloni E; Alunno A; Gattamelata A; Maset M; Modesti M; Tavoni A; De Vita S; Gerli R; Valesini G; Bombardieri S
Rheumatology (Oxford); 2014 May; 53(5):839-44. PubMed ID: 24369420
[TBL] [Abstract][Full Text] [Related]
7. Relation of systemic autoantibodies to the number of extraglandular manifestations in primary Sjögren's Syndrome: a retrospective analysis of 65 patients in the Netherlands.
ter Borg EJ; Risselada AP; Kelder JC
Semin Arthritis Rheum; 2011 Jun; 40(6):547-51. PubMed ID: 20864144
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies against complement 3 neoantigens for detection of immune complexes and complement activation. Relationship between immune complex levels, state of C3, and numbers of receptors for C3b.
Aguado MT; Lambris JD; Tsokos GC; Burger R; Bitter-Suermann D; Tamerius JD; Dixon FJ; Theofilopoulos AN
J Clin Invest; 1985 Oct; 76(4):1418-26. PubMed ID: 2932466
[TBL] [Abstract][Full Text] [Related]
9. Hypocomplementaemia as an immunological marker of morbidity and mortality in patients with primary Sjogren's syndrome.
Ramos-Casals M; Brito-Zerón P; Yagüe J; Akasbi M; Bautista R; Ruano M; Claver G; Gil V; Font J
Rheumatology (Oxford); 2005 Jan; 44(1):89-94. PubMed ID: 15381790
[TBL] [Abstract][Full Text] [Related]
10. Nephritic factor (NeF) of alternate pathway (NeFA) and of classical pathway (NeFc).
Arakawa M; Seino J; Kinoshita Y; Fukuda K; Saito T; Furuyama T
Tohoku J Exp Med; 1982 Dec; 138(4):401-9. PubMed ID: 6897686
[TBL] [Abstract][Full Text] [Related]
11. Immune complexes in Sjögren's syndrome.
Fischbach M; Char D; Christensen M; Daniels T; Whaley K; Alspaugh M; Talal N
Arthritis Rheum; 1980 Jul; 23(7):791-5. PubMed ID: 6902669
[TBL] [Abstract][Full Text] [Related]
12. Dual anti-neutrophil cytoplasmic antibody-related pauci-immune crescentic glomerulonephritis in a patient with Sjögren's syndrome.
Lee IH; Kim SK; Kim MK
Rheumatol Int; 2016 Sep; 36(9):1327-34. PubMed ID: 27384449
[TBL] [Abstract][Full Text] [Related]
13. Association of Sjögren's syndrome with C4 deficiency, defective reticuloendothelial function and circulating immune complexes.
Hersey P; Lawrence S; Prendergast D; Bindon C; Benson W; Valk P
Clin Exp Immunol; 1983 Jun; 52(3):551-60. PubMed ID: 6872316
[TBL] [Abstract][Full Text] [Related]
14. Lower prevalence of extra-glandular manifestations and anti-SSB antibodies in patients with primary Sjögren's syndrome and widespread pain: evidence for a relatively benign subset.
ter Borg EJ; Kelder JC
Clin Exp Rheumatol; 2014; 32(3):349-53. PubMed ID: 24529195
[TBL] [Abstract][Full Text] [Related]
15. Immune reactants in cryoproteins. Relationship to complement activation.
Wilson MR; Arroyave CM; Miles L; Tan EM
Ann Rheum Dis; 1977 Dec; 36(6):540-8. PubMed ID: 339851
[TBL] [Abstract][Full Text] [Related]
16. Clinical and biological differences between cryoglobulinaemic and hypergammaglobulinaemic purpura in primary Sjögren's syndrome: results of a large multicentre study.
Quartuccio L; Isola M; Baldini C; Priori R; Bartoloni E; Carubbi F; Gregoraci G; Gandolfo S; Salvin S; Luciano N; Minniti A; Alunno A; Giacomelli R; Gerli R; Valesini G; Bombardieri S; De Vita S
Scand J Rheumatol; 2015; 44(1):36-41. PubMed ID: 25268749
[TBL] [Abstract][Full Text] [Related]
17. Serum soluble Fas/APO-1 is increased in patients with primary Sjögren's syndrome.
Fujihara T; Takeuchi T; Tsubota K; Kayagaki N; Yagita H; Okumura K; Abe T
Clin Rheumatol; 1998; 17(6):496-9. PubMed ID: 9890678
[TBL] [Abstract][Full Text] [Related]
18. Clinical and serologic features of primary Sjögren's syndrome concomitant with autoimmune hemolytic anemia: a large-scale cross-sectional study.
Wen W; Liu Y; Zhao C; Sun X; Zhang C; Li Z
Clin Rheumatol; 2015 Nov; 34(11):1877-84. PubMed ID: 26423426
[TBL] [Abstract][Full Text] [Related]
19. Serum angiotensin converting enzyme in Sjogren's syndrome--a case report and study of 21 further cases.
Machin ND; Chard MD; Paice EW
Postgrad Med J; 1984 Apr; 60(702):270-1. PubMed ID: 6328467
[TBL] [Abstract][Full Text] [Related]
20. Update on Sjögren's syndrome autoimmune epithelitis: from classification to increased neoplasias.
Tzioufas AG; Voulgarelis M
Best Pract Res Clin Rheumatol; 2007 Dec; 21(6):989-1010. PubMed ID: 18068857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
